Navigating the dynamic landscape of lower-risk MDS: Advances and emerging insights
Mina A, Madanat Y, Abaza Y, Zeidan A. Navigating the dynamic landscape of lower-risk MDS: Advances and emerging insights. Blood Reviews 2025, 101301. PMID: 40450506, DOI: 10.1016/j.blre.2025.101301.Peer-Reviewed Original ResearchAcute myeloid leukemiaLR-MDSErythropoiesis stimulating agentsIncreased risk of transformation to acute myeloid leukemiaMolecular International Prognostic Scoring SystemRisk of transformation to acute myeloid leukemiaTransformation to acute myeloid leukemiaAllogeneic hematopoietic stem cell transplantationInternational Prognostic Scoring SystemHematopoietic stem cell transplantationClonal myeloid malignanciesPrognostic scoring systemStem cell transplantationPredominant clinical manifestationLowered riskClinical trial designIneffective hematopoiesisCurative optionMyeloid malignanciesCell transplantationIndolent natureTransfusion supportImprove patient outcomesMyeloid leukemiaClinical manifestations
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply